PMEL and carcinoma: Immunohistochemistry further guided the diagnosis: diffuse positivity for S-100, and HMB-45 supported melanocytic differentiation, but the lack of cytokeratin and epithelial membrane antigen (EMA) expression excluded carcinoma and chordoma[22], respectively.